Category: Life Sciences
United States Life Sciences
-
US Vascular Grafts Market Size study, by Product (Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts), By Raw Material (Synthetic Vascular Grafts, Biological
... Hybrid Vascular Grafts), By Application (Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease) Forecasts 2022-2032 US Vascular Grafts Market is valued approximately USD 485 million in 2023 and is anticipated to grow with a ... Read More
-
US Dosing Systems Market Size study, by Type (Diaphragm Pump, Piston Pump, Other Types) by Application (Oil and Gas, Water and Sewage Treatment, Chemicals, Other Applications) Forecasts 2022-2032
... USD 654 million in 2023 and is anticipated to grow with a healthy growth rate of more than 3.34% over the forecast period 2024-2032. Dosing systems are precision instruments used to accurately dispense specific quantities ... Read More
-
US Trypsin Market Size study, By Source (Porcine, Bovine, Others), By Application (Biotechnology and Pharmaceutical Industry, Food Industry, Cosmetics and Personal Care, Waste Treatment, Others), By End-use (Research, Diagnostics, Industrial use), Forecas
... Market is valued at approximately USD 25.97 million in 2023 and is anticipated to grow with a healthy growth rate of more than 3.98% over the forecast period 2024-2032. Trypsin, a vital digestive enzyme synthesized ... Read More
-
Cannabis Market In Us 2024-2028
... cannabis market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
US Pneumococcal Vaccine Market Size study, by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine) by Product (Prevnar 13, Synflorix, Pneumovax 23, Vaxneuvance, Pneumosil, Other Products) by End-use (Public Sector, Private Sector) Forecasts 2022-2032
... Pneumococcal Vaccine Market is valued approximately USD 3.67 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.90% over the forecast period 2024-2032. The Pneumococcal Vaccine is a ... Read More
-
Pet Care
... at a CAGR of 6.0% over the analysis period 2023-2030. Pet Food, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$136.3 Billion by the end of ... Read More
-
Aesthetic Services
... at a CAGR of 6.9% over the analysis period 2023-2030. Surgical Procedure, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$17.1 Billion by the end of ... Read More
-
Coenzyme Q10
... at a CAGR of 4.6% over the analysis period 2023-2030. Dietary Supplements Application, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$609.1 Million by the end ... Read More
-
Cycling Power Meters
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Crank Arm-Based Cycling Power Meters, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach ... Read More
-
Infrared Thermometers
... at a CAGR of 7.4% over the analysis period 2023-2030. Forehead Thermometers, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Healthcare Distribution
... at a CAGR of 13.9% over the analysis period 2023-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$2.3 Trillion by the end of ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
Forensic Technologies and Services
... reach US$41.5 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach ... Read More
-
Personal Finance Software
... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Web-based Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$941.0 Million by ... Read More
-
Computer Aided Detection (CAD)
... reach US$2.0 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. Mammography Modality, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach ... Read More
-
Automated and Rapid Microbiological Tests
... is expected to reach US$10.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. GC/CRT (Clinical) Application, one of the segments analyzed in the report, is expected to record a ... Read More
-
Generic Drugs
... at a CAGR of 6.6% over the analysis period 2023-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of ... Read More
-
Home Cleaning Services
... by 2030, growing at a CAGR of 8.8% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 11.9% CAGR The Home Cleaning Services market ... Read More
-
OTT Devices and Services
... reach US$467.9 Billion by 2030, growing at a CAGR of 17.9% over the analysis period 2023-2030. Video Content, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach ... Read More
-
Soldier Systems
... at a CAGR of 5.0% over the analysis period 2023-2030. Personal Protection, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Biotechnology Product Manufacturing
... (all based in the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
COVID-19 Testing
... at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end ... Read More
-
United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices and Pharmaceuticals), Pain Type, Drug Class, Indication, Distribution Channel and Company Analysis 2024-2032
... Therapeutics Market will reach US$ 36.15 billion by 2032, up from US$ 26.18 billion in 2023, with a CAGR of 3.65% between 2024 and 2032. Many factors are driving the market's rapid expansion such as ... Read More
-
Radiopharmaceuticals
... of 11.0% over the analysis period 2023-2030. SPECT Radioisotopes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$6.2 Billion by the end of the analysis period. ... Read More
Research Assistance
